BBI Life Sciences Corporation (SEHK:1035) entered into an equity transfer agreement to acquire Bionics Co., Ltd. for $2.4 million on September 3, 2016. Pursuant to the transaction, Bionics will become an indirect wholly-owned subsidiary of BBI Life Sciences Corporation. BBI Life Sciences Corporation (SEHK:1035) completed the acquisition of Bionics Co., Ltd. on October 25, 2016. All conditions precedent under the agreement have been satisfied.